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Aim. Dental biofilms play a major role in the pathogenesis of many dental diseases. In this study, we evaluated the synergistic
effect of atmospheric pressure plasma and different agents in dentistry on the reduction of biofilms.Methods and Results. We used
monospecies (S. mutans) and multispecies dental biofilm models grown on titanium discs in vitro. After treatment with one of
the agents, the biofilms were treated with plasma. Efficacy of treatment was determined by the number of colony forming units





multispecies biofilms the combination with plasma achieved a higher CFU reduction than each agent alone. We found an additive
antimicrobial effect between argon plasma and agents irrespective of the treatment order with cultivation technique. For EDTA and
octenidine, antimicrobial efficacy assessed by live-dead staining differed significantly between the two treatment orders (𝑃 < 0.05).
Conclusions. The effective treatment of dental biofilms on titanium discs with atmospheric pressure plasma could be increased by
adding agents in vitro.
1. Introduction
Plasma is the fourth state of matter besides the solid, liquid,
and gaseous states. It is an ionized gas consisting of ions, a
broad spectrum of radicals, ultraviolet irradiation, electric
fields, and ozone, which are responsible for its antimicrobial
efficacy [1].
Atmospheric pressure plasma is also called nonthermal
plasma, because it can achieve body temperature [2]. This
allows medical application to humans by small plasma hand
device on humans [3]. Plasma medicine is a new scientific
field, and many research groups investigated various appli-
cations, for example, to the treatment of dental diseases
like periodontitis [4], peri-implantitis [5], and caries and
denture stomatitis [6] as well as dermatological diseases and
chronic wounds [1, 7, 8]. Most applications were based on the
antimicrobial effect of plasma to disinfect the skin, implants,
and other medical devices. To date antiseptics have been
commonly applied in these cases.
Plasma is especially interesting for fields with a dissatis-
factory standard therapy or where an effective therapy does
not exist, for example, peri-implantitis therapy in dentistry.
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The antimicrobial efficacy of plasma could be increased by
raising the electrical input power [9, 10]. However, plasma
should also be tissue tolerable and applicable to humans. As
with any active substance the balance between efficacy and
tolerability needs to be found.
To enhance plasma effects without an increased input
power, we investigated possible synergistic effects between
atmospheric pressure plasma and different antiseptics includ-
ing chlorhexidine, octenidine, and polyhexanide aswell as the
chemicals sodiumhypochlorite and hydrogen peroxide, often
used in dental practice, and the chelating agent EDTA.
2. Material and Methods
We used three different dental biofilm models grown on
titanium, the typical dental implant material. Titanium discs
were machined and had a diameter of 5mm and 1mm
thickness (Straumann, Basel, Switzerland).
2.1. Monospecies Biofilm Streptococcus mutans. Streptococ-
cus mutans (S. mutans DSM 20523, German collection
of microorganisms and tissue culture cells, Braunschweig,
Germany), a strain often utilized for antimicrobial tests, was
grown overnight at 37∘ConColumbia sheep blood agar (BBL,
BD, Heidelberg, Germany). One inoculation loop of this
culture was resuspended into 30mL Brain Heart Infusion
(BHI) (BD, BBL, Heidelberg, Germany) complemented with
1% sucrose [11]. The sterile titanium discs were positioned
in 96-well microtiter plates (Techno Plastic Products AG,
Trasadingen, Switzerland), covered with 100 𝜇L S. mutans
suspension, and incubated aerobically at 37∘C. For S. mutans,
we deliberately used no surface coatingwith salivary proteins,
since this reduces the contact angle of titanium, and, con-
sequently, adhesion of S. mutans would be reduced [12]. In
preliminary tests we achieved the best biofilm forming results
without a conditioning film. Every 24 h BHI was changed.
After 72 h the medium was drawn off, the discs were washed
with 0.9% NaCl solution and transferred into a new, sterile
microtiter plate.
2.2. Multispecies Saliva Biofilm. To simulate a perimucositis
situation, we used amultispecies saliva biofilm. Unstimulated
saliva was taken from healthy donors (𝑛 = 5, pooled saliva,
mean age 29 ± 7 years, nonsmokers) as a source of oral
microbiota. This was approved by the local ethics committee
(BB 120/10). Saliva donors did not take any medication three
months prior to the study and did not have active carious
lesions or overt periodontal disease. In the saliva of three
donors we foundAggregatibacter actinomycetemcomitans and
Porphyromonas gingivalis, and Fusobacterium nucleatum in
four donors and Streptococcus sanguinis in all five donors in
a PCR analysis. These bacteria are typically associated with
periodontitis, perimucositis, or peri-implantitis.
Sterile titanium discs were covered with 100 𝜇L saliva
and incubated aerobically at 37∘C. We deliberately used no
previous surface coating with salivary proteins, because we
inoculated full saliva containing all proteins. The further
procedure was as described above.
2.3. Multispecies Subgingival Biofilm. To study possible syn-
ergistic effects in an anaerobic milieu, we used a multi-
species subgingival biofilm. Subgingival plaque was obtained
from five periodontal patients (pooled plaque, mean age
50 ± 10 years). It was removed with a dental curet and
resuspended in Schädler broth with vitamin K1 (BD, BBL,
Heidelberg, Germany). The plaque was incubated at 37∘C
overnight under anaerobic conditions using the Anaerocult
A system (Merck, Darmstadt, Germany) to develop a biofilm.
Before biofilm formation the sterile titanium discs were
conditioned with DTT saliva. To this end, 10mL saliva was
collected from healthy donors, pooled, and treated with
5mL 1M DL-dithiothreitol solution (DTT, Sigma-Aldrich,
Steinheim, Germany) and 5mL distilled water. This DTT
saliva mixture was then centrifuged (Mini Spin, Eppendorf,
Hamburg Germany). Thereafter the supernatant was filtered
through a 0.2𝜇m pore filter (HVM Filtramed, Rotenburg
an der Fulda, Germany) and frozen at −20∘C until use.
The titanium discs were covered with 500𝜇L DTT saliva
and incubated 2 h at 37∘C. Afterwards the DTT saliva was
carefully removed, and 1mL plaque suspension was added
and incubated anaerobically at 37∘C.
2.4. Antiseptic and Chemical Pretreatment. Titanium discs
were pretreated with 0.1% chlorhexidine digluconate (CHX,
aqueous solution, Fagron GmbH & Co KG, Barsbüttel,
Germany), 0.1% octenidine dihydrochloride (OCT, Schülke
& Mayr GmbH, Norderstedt, Germany), 0.1% polihexanide
(PHMB, B. Braun, Melsungen, Germany), 0.6% sodium
hypochlorite (NaOCl, AppliChem GmbH, Darmstadt, Ger-





Darmstadt, Germany), and 20% ethylenediaminetetraacetic
acid (EDTA, AppliChem GmbH, Darmstadt, Germany). As
negative control we used 0.9%NaCl solution, hereafter called
“NaCl control.”
Biofilm discs were covered with 100𝜇L of the substances
and incubated for 30min. Within this incubation time,
antiseptically pretreated biofilms were treated 1min with
plasma. Afterwards the antiseptic effect was halted by adding
1mL inactivator. For inactivating PHMB effects we used
30 g/L Tween 80, 30 g/L saponin, 1.0 g/L histidin, and 1.0 g/L
cystein. For CHX, OCT, and EDTA, the inactivator was
Lipofundin MCT 20% (B. Braun, Melsungen, Germany). An
inactivator consisting of 30 g/L Tween 80, 3 g/L lecithin, 1 g/L
histidin and 5 g/L sodium thiosulfate was used to stop the




. All inactivators were proven by
the quantitative suspension test according to DIN EN 1040
(German Institute for Standardisation).
2.5. Plasma Treatment. To test the resistance of antiseptics
against plasma treatment, we treated 5mL of each antiseptic
for 1 and 10min with plasma. By spectral measurement
(CHX: 231 nm, OCT: 213 nm, PHMB: 235 nm) we compared
measurement results after plasma treatment with untreated
antiseptics.
For plasma generation we used the atmospheric pressure
plasma jet kINPen 09 (neoplas tools, Greifswald, Germany)
[8]. Argon (Ar) gas flow was set to 5 slm (standard liters per
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minute). The flow rate was controlled by a flow controller
(MKS Instruments, Munich, Germany). We had a constant
pin-to-disc distance of 7mm during the application. The
kINPenwas fixed in a computer driven 3 axes (𝑥, 𝑦, 𝑧)motor-
ized stage, under which a 96-well plate with the titanium
discs was positioned. The plasma devices were consecutively
driven from well to well, positioned centrally over the discs
and remained in position for 1min. To assess the effects of
biofilm dehydration by gas flow, biofilmswere treatedwith Ar
gas without plasma generation. Additionally we investigated
biofilms without gas or plasma treatment, hereafter called
“control procedure.”
After plasma treatment, titanium discs were placed into
wells with 200 𝜇L 0.9% NaCl solution and the biofilm
was removed by ultrasonic scaling. Serial dilutions of the
resuspended biofilm solution were made by transferring
0.1mL of the resultant suspension to 0.9mL of fresh 0.9%
NaCl solution. Afterwards an aliquot portion of 0.1mL from
each dilution was plated on Columbia sheep blood agar
(BBL, BD, Heidelberg, Germany) and incubated aerobically
at 37∘C for 48 h for S. mutans and saliva. Resuspended plaque
biofilms were plated on Schädler agar (BBL, BD, Heidelberg,
Germany) and incubated anaerobically at 37∘C for 48 h. The
colonies were counted and expressed as colony forming units
(CFU/mL).
2.6. Change in Treatment Order. In an additional experiment
we changed the treatment order because we wanted to test
the hypothesis that EDTA destroys the biofilm matrix to
increase the plasma effect and that a higher antimicrobial





treatment is observable. First saliva biofilmswere treatedwith




was added. After 30min
the antiseptic effect was halted by adding 1mL inactivator as
described above. Then, CFUs were determined.
2.7. Live-Dead Staining. Biofilms on discs were stained with
fluorescein diacetate (FDA) and ethidium bromide (EB) to
selectively stain living (green) and dead (red) bacteria [13].
Thereby 6𝜇L of a FDA stock solution (5mg/mL) and 3 𝜇L of
an EB stock solution (1.25mg/mL) were mixed in 1mL 0.9%
NaCl solution. The fluorescence was measured at excitation
wavelengths of 485 nmand 530 nmand emissionwavelengths
of 530 nm and 630 nm on Berthold TriStar LB 941 (Berthold
Technologies, Bad Wildbad, Germany). The division of the
green fluorescent signal by the red fluorescent signal yielded
the live-dead ratio. With the live-dead staining we tested the
antimicrobial effect with all agents in both treatment orders
on saliva biofilms. Additionally, samples were observed using
a Zeiss CLSM510 Exciter confocal laser scanning microscope
(Carl Zeiss MicroImaging GmbH, Jena, Germany). Using
Live-dead staining the antimicrobial effect was tested with all
agents in both treatment orders on saliva biofilms.
2.8. Statistics. For all analyses, observed CFU values were
transferred to their base 10 logarithm (referred to as
log
10
CFU; for S. mutans: log
10
(CFU + 1)). Continuous data
are presented as mean ± standard deviation (SD).
The log
10
-reduction factor (RF) for each treatment
method was calculated [14].
To examine differences in log
10
CFU values between
different procedures and admixture combinations, log
10
CFU
values were compared for each agent versus the NaCl control
within each procedure (within columns of Table 1) and for
each agent; differences between the NaCl control, Ar gas, and
Ar plasma were pairwise evaluated (within rows of Table 1)
using two-sided Mann-Whitney 𝑈 tests. To adjust for mul-
tiple testing within each step (comparisons within columns,




CFU values across different pro-
cedures (control procedure, Ar gas, and Ar plasma) and





and EDTA) were evaluated using linear regression analyses
including the twofold interaction term of both factors (sig-
nificant at 𝑃 < 0.10). Linear regression coefficients with their
95% confidence intervals (CI) were reported. 𝑅2 quantifies
the amount of variation explained by the model.
Differences of live-dead ratios across combinations of
procedures and admixtures were evaluated using two-sided
Mann-Whitney-𝑈-tests.𝑃 values were corrected according to
Bonferroni.
Statistical differences were considered significant at a
level alpha of 5%. Statistical analyses were performed with
STATA/SE 10.0 (Stata Corp LP, College Station, TX,USA) and
R 2.13.0 (R Development Core Team, 2011).
3. Results
Themeasured spectral data of the antiseptics before and after
plasma treatment were identical (OCT: 0.5, CHX: 1, PHMB:
1.1), indicating that the agents were not modified by plasma.
3.1. Log10CFU Values after Administration of Agent Plus
Plasma/Gas
3.1.1. S. mutans Biofilm. The highest CFU reduction with no
colonies being detected (values below detection limit) was






Compared with the control procedure, all agents lead to
significantly lower CFU values compared with the negative
control (𝑃 < 0.05). In combination with Ar gas, admixture of
CHX (RF = 1.96), OCT (RF = 1.90), PHMB (RF = 3.39),




(RF = 6.91) significantly
reduced CFU values compared with NaCl controls. In com-
bination with Ar plasma, admixture of PHMB (RF = 3.36),




(RF = 6.91), and EDTA (RF =
2.78) significantly reduced CFU values compared with NaCl
controls.
Compared with the control procedure, only Ar plasma
significantly reduced log
10
CFU values when combined with
NaCl control, PHMB, or EDTA (𝑃 < 0.05). For admixtures






CFU values did not


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2: Linear regression models evaluating effects of different agents and plasma procedures on lg (CFU/mL + 1) for S. mutans, saliva, and
subgingival biofilms (first agent then plasma).
S. mutans (𝑁 = 178, 𝑅2 = 98.4%) Saliva (𝑁 = 329, 𝑅2 = 72.6%) Subgingival (𝑁 = 175, 𝑅2 = 76.3%)
B (95% CI) P B (95% CI) P B (95% CI) P
Agent (ref. NaCl control)
CHX −1.78 (−2.06; −1.50) <0.001 −0.29 (−0.59; 0.02) <0.001 −0.74 (−1.12; −0.36) <0.001
OCT −1.84 (−2.12; −1.56) <0.001 −0.79 (−1.10; −0.49) <0.001 −1.54 (−1.91; −1.16) <0.001
PHMB −2.51 (−2.81; −2.22) <0.001 −0.87 (−1.22; −0.53) <0.001 −0.96 (−1.34; −0.58) <0.001
NaOCl −6.91 (−7.20; −6.61) <0.001 −2.39 (−2.89; −1.90) <0.001 −1.76 (−2.14; −1.38) <0.001
H2O2 −6.91 (−7.19; −6.63) <0.001 −1.50 (−1.94; −1.06) <0.001 −1.89 (−2.27; −1.51) <0.001
EDTA −1.11 (−1.38; −0.84) <0.001 −0.64 (−1.08; −0.19) 0.005 −1.74 (−2.12; −1.36) <0.001
Procedure (ref. control)
Ar gas −0.35 (−0.63; −0.07) 0.02 −0.42 (−0.76; −0.07) 0.02 −1.34 (−1.64; −1.04) <0.001
Ar plasma −2.10 (−2.34; −1.87) <0.001 −1.49 (−1.76; −1.22) <0.001 −2.16 (−2.46; −1.86) <0.001
Interaction agent × procedure
CHX × Ar gas 0.18 (−0.25; 0.60) 0.42 −0.68 (−1.17; −0.19) 0.008 0.24 (−0.31; 0.79) 0.40
OCT × Ar gas 0.29 (−0.14; 0.71) 0.19 −0.58 (−1.10; −0.61) 0.03 0.22 (−0.33; 0.78) 0.43
PHMB × Ar gas −0.53 (−0.99; −0.07) 0.02 0.15 (−0.44; 0.75) 0.61 0.44 (−0.12; 0.99) 0.12
NaOCl × Ar gas 0.35 (−0.10; 0.79) 0.12 −0.07 (−0.78; 0.64) 0.84 1.35 (0.80; 1.91) <0.001
H2O2 × Ar gas 0.35 (−0.09; 0.78) 0.12 0.08 (−0.59; 0.75) 0.81 1.38 (0.83; 1.94) <0.001
EDTA × Ar gas 0.19 (−0.22; 0.61) 0.36 0.32 (−0.33; 0.98) 0.33 1.05 (0.50; 1.61) <0.001
CHX × Ar plasma 1.93 (1.53; 2.33) <0.001 0.08 (−0.34; 0.50) 0.72 0.91 (0.35; 1.46) 0.001
OCT × Ar plasma 2.09 (1.70; 2.49) <0.001 −0.51 (−0.92; −0.10) 0.02 1.70 (1.15; 2.25) <0.001
PHMB × Ar plasma 1.26 (0.85; 1.68) <0.001 0.80 (0.35; 1.25) 0.001 1.04 (0.49; 1.60) <0.001
NaOCl × Ar plasma 2.10 (1.70; 2.51) <0.001 0.81 (0.16; 1.47) 0.02 2.27 (1.72; 2.82) <0.001
H2O2 × Ar plasma 2.10 (1.70; 2.50) <0.001 0.57 (−0.05; 1.19) 0.07 1.12 (0.57; 1.67) <0.001
EDTA × Ar plasma 0.44 (0.04; 0.84) 0.03 −0.69 (−1.31; −0.08) 0.03 1.82 (1.26; 2.37) <0.001
Ar: argon; CHX: 0.1% chlorhexidine; OCT: 0.1% octenidine; PHMB: 0.1% polyhexanide; NaOCl: 0.6% sodium hypochlorite; H2O2: 1.5% hydrogen peroxide;
EDTA: 20% ethylenediaminetetraacetic acid.
EDTA, log
10
CFU values were significantly reduced for Ar
plasma compared with Ar gas (𝑃 < 0.05).
To evaluate the impact of procedure and agents on S.
mutans CFU values, linear regression models were evaluated
(Table 2). The model explained 98.4% of the variation in
observed CFU values. Procedure, admixture, and the inter-
action of both were significantly related to log
10
(CFU/mL)
values (𝑃 < 0.001). Post hoc analysis confirmed that any




was significantly the best
performing combination among those tested (𝑃 < 0.001)




3.1.2. Saliva Biofilm. The highest reduction in log
10
CFU
was found for the combination of Ar plasma with NaOCl
(RF = 3.06, Table 1). Compared with the control procedure,




, and EDTA led
to significantly lower CFU values compared with the NaCl
control (𝑃 < 0.05). Combined with Ar gas, admixture of





compared with NaCl control (𝑃 < 0.05). The effect of Ar
plasma on CFU reduction was significantly enhanced by
OCT, NaOCl, and EDTA compared with the NaCl control.
Compared with the control procedure, application of
Ar gas significantly reduced CFU values when CHX or
OCT was applied previously (𝑃 < 0.05). Compared with
the control procedure, Ar plasma treatment significantly
enhanced antimicrobial effects of NaCl control, CHX, OCT,
PHMB, and EDTA (𝑃 < 0.05). For NaCl control, OCT and
EDTA, Ar plasma performed significantly better compared
with Ar gas (𝑃 < 0.05).
For the combination of plasma and agents, the simple
additive effect on log
10
CFU reduction was partly exceeded.
Compared with single reduction factors for plasma and CHX
(RF = 1.48 and RF = 0.28, resp.), the combined RF was 1.70
(Table 1).
Estimating the impact of procedure and agents on saliva
log
10
CFU values more closely (Table 2), linear regression
models were performed, which explained 72.5% of the
variation in observed CFU values. Procedure, admixture,
and the interaction of both were significantly related to
log
10
CFU values (𝑃 < 0.001). Post hoc analyses revealed
that the combination of Ar plasma with NaOCl was the
best performing combination among those tested with a
predicted reduction of 3.07 log
10
CFUcomparedwith the total
negative control (NaCl control with control procedure). It
was significantly better compared with most combinations
but similarly effective compared with Ar gas combined with
NaOCl (𝑃 = 0.52), Ar plasma combined with OCT (𝑃 =
0.22), and Ar plasma combined with EDTA (𝑃 = 0.38).
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3.1.3. Subgingival Biofilm. The highest log
10
CFU reduction




(4.41 ± 0.86, Table 1).
For the control procedure any admixture led to significantly
reduced log
10
CFU values compared with NaCl control (𝑃 <
0.05). With Ar gas, only the admixture of OCT was bene-
ficial (log
10
CFU 4.68 ± 1.53). Regardless of the admixture,




Considering the effect of the three procedures within
agents, both Ar gas and Ar plasma significantly reduced
log
10
CFU values compared with the control procedure for




. For PHMB, NaOCl, and EDTA,
log
10
CFU values did not differ significantly across proce-







significantly reduced for Ar plasma compared with Ar gas.
The overall best log
10
CFU reduction was achieved when Ar





To evaluate the impact of procedure and agents on plaque
log
10
CFU values, linear regression models were evaluated
(Table 2). While 76.3% of the variation in observed log
10
CFU
valueswere explained, procedure, admixture, and the interac-
tion of bothwere significantly related to log
10
CFU values(𝑃 <
0.001). Post hoc analyses revealed that the combination of




was significantly the best performing
combination among those tested (𝑃 < 0.001) with the
exception of Ar gas with OCT (𝑃 = 0.25). The combination




had a predicted reduction of 2.92
log
10
CFU compared with the total negative control (NaCl
control with control procedure).
3.2. Log10CFU Values after Administration of Plasma Plus
Agent . To evaluatewhether the reduction inCFUwas related
to the procedure or the admixture, the treatment order
was changed; that is, plasma or gas was applied before the
admixture of agents (Table 3).The data were comparable with
those of Table 1. The extent of log
10
CFU reduction relative to
the total negative control was comparable, irrespective of the
treatment order. For example, the combination of EDTA plus
Ar plasma achieved a log
10
CFU reduction of RF = 2.81, while
the combination of both in reversed treatment order achieved
a log
10





with Ar plasma, respective log
10
CFU reductions were
2.41 and 2.58. Accordingly, we found an additive effect of














(> 1.35 + 1.00). The same figures applied to the combination
of plasma (RFplasma = 1.35) with EDTA (RFEDTA = 1.25) and
plasma + EDTA: RFplasma+EDTA = 2.66(∼ 1.35 + 1.25).
3.3. Live-Dead Staining. To determine the antimicrobial
effect of all combinations with both treatment orders, we
stained the biofilms with EB and FDA (Figure 1). A reduction
of the living microorganisms in % can be explained by a
reduced FDA fluorescence or an increased EB fluorescence
signal, resulting in a higher number of dead cells.Thenegative
control achieved amean value of 100%. For Ar plasma treated
cells the value decreased to 45.3%. After EDTA treatment the
mean living microorganisms of 56.4% were further reduced
Table 3: Logarithm of saliva biofilm CFU/mL after treatment with
different procedures (control compared with Ar gas or Ar plasma)
and different agents (NaCl,H2O2, and EDTA) in changed order (first
plasma then agent treatment).
Agent Procedure
Control Ar gas Ar plasma



























Data are presented as mean lg (CFU/mL + 1) ± SD.
Ar: argon; CHX: 0.1% chlorhexidine; OCT: 0.1% octenidine; PHMB: 0.1%
polyhexanide; NaOCl: 0.6% sodium hypochlorite; H2O2: 1.5% hydrogen
peroxide; EDTA: 20% ethylenediaminetetraacetic acid.
∗
𝑃 < 0.05 versus NaCl control (within columns); ∗∗P < 0.05 versus control
procedure (within rows); #P < 0.05 comparing Ar plasma versus Ar gas
(within rows), two-sided Mann-Whitney U test, and reduction in saliva









































Figure 1: Green fluorescence (fluoresceindiacetate (FDA); alive):
red fluorescence (ethidiumbromide (EB); damaged membrane
dead) ratio of saliva biofilms after treatment with different proce-
dures. Data are presented as mean ± SD (𝑛 = 8). ∗𝑃 < 0.05
versus NaCl control (within equally colored columns); ∗∗𝑃 < 0.05
versus Agent only for each agent separately; #𝑃 < 0.05 Plasma plus
Agent versus Agent plus plasma for each agent separately. 𝑃 values
were retrieved from Mann-Whitney-𝑈 tests and were Bonferroni
corrected.
to 17.3% after additional plasma treatment. When EDTA
treatment was applied after Ar plasma treatment, no additive
effect was found (51%). Both values differed significantly
between the two treatment orders (𝑃 < 0.05).
Concerning antiseptics, additional Ar plasma treatment
consistently decreased the mean ratio with only minimal
differences between either treatment order (CHX: 24.4%,
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CHX + Ar plasma: 8.6%, and Ar plasma + CHX: 14.2%;
OCT: 28.6%, OCT + Ar plasma: 3.4%; Ar plasma + OCT:
14.17; PHMB: 73%; PHMB + Ar plasma: 18.7%, Ar plasma +
PHMB: 28.8%). Applying the antiseptic treatment before Ar
plasma treatment led to slightly fewer living microorganisms
compared with the other treatment order.This difference was
significant (𝑃 < 0.05) for OCT. For NaOCl, the lowest ratio
was achieved when plasma treatment was applied prior to
NaOCl treatment (17.4%; 21.9% when Ar plasma treatment
was applied after NaOCl treatment). The highest reduction




(5.4%). With prior (posterior) Ar
plasma treatment the ratio was 1.6% (2.2%).
Using confocal laser scanning microscopy (Figure 2)





pronounced in the center of the disc, where no green
fluorescence was visible. Themicrographs for both treatment
orders for the combination of EDTA and Ar plasma were
comparable. Using the same microscopic settings the micro-
graphs of Ar plasma and antiseptic after treated biofilms were
comparable to those of EDTA and Ar plasma. Therefore the
pictures have not been presented here.
4. Discussion
In this study we found an additive antimicrobial effect
between Ar plasma and agents irrespective of the treatment
order regarding cultivation. Concerning Live-dead staining
we found different antimicrobial effects dependent on treat-
ment order.
Decontamination of dental implants is a promising appli-
cation of plasma devices. To investigate synergistic effects
between Ar plasma and agents, we used three different
biofilm models.
In this study, sensitivity to treatments differed signifi-
cantly between our biofilm models. Monospecies S. mutans
biofilms were more susceptible to antimicrobial treatments
than our multispecies biofilm models. S. mutans biofilm is
no satisfactory model to test antibiofilm efficacy, because it
cannot mimic oral conditions in an adequate way. Therefore
we used biofilms cultured from ex vivo saliva and subgingival
dental plaque to test Ar plasma in more realistic models. It
was shown that Gram-negative as well as anaerobic bacteria
are more sensitive to plasma than Gram positives or aerobic
ones [15]. In multispecies saliva and subgingival biofilms
we found both Gram-negative and -positive bacteria. We
detected the highest CFU reduction byAr plasma for the sub-
gingival plaque biofilm. However, during biofilm processing
we could not maintain the anaerobic atmosphere, which may
have distorted the antimicrobial effect of the treatments.
Using only culture-based techniques to determine
antimicrobial effects bears some disadvantages. Bacteria can
exist in a viable but nonculturable state (VBNC) [16]. VBNC
bacteria cannot be detected using culture-based techniques.
Additionally, not all species in our multispecies biofilm grow
on sheep blood agar. Therefore we used Live-dead staining
with a microscopic and a spectroscopic analysis in saliva








Agent Plasma + agent Agent + plasma
Figure 2: Fluorescence staining ofsaliva biofilms on titanium discs














The biofilms were stained with fluoresceindiacetate (FDA) and
ethidiumbromide (EB) to selectively stain living (green) and dead
(red) bacteria.
In this study, we found additive effects betweenAr plasma
and agents. To understand the magnitude of these effects,
we compared the CFU and live-dead ratio reduction of Ar
plasma and the agents and the CFU and live-dead-ratio
reduction of the combination of both.
Concerning culture-based technique, the antibiofilm
effect of Ar plasma was significantly increased for S. mutans





treatment. With anaerobic multispecies





and Ar plasma, which was also the procedure with the
highest log
10
CFU reduction of saliva biofilm. For aerobic
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multispecies saliva biofilms significant additive effects
between Ar plasma and EDTA and OCT were found.
Log
10
CFU reductions for combined treatments were always
higher than single Ar plasma or single agent treatments.
Treatment order differed significantly between addition
of EDTA and octenidine before or after plasma application
(𝑃 < 0.05) when we evaluated the results with Live-dead
staining. When EDTA treatment was applied after Ar plasma
treatment, no additive effect was found. Concerning antisep-
tics, additional Ar plasma treatment consistently decreased
the mean ratio irrespective of the treatment order. For
NaOCl, the lowest ratio was achieved when plasma treatment
was applied prior to NaOCl treatment.The highest reduction





To our knowledge there are no studies that have inves-
tigated the combined effects of agents and plasma. To
understand our observed results, we limit the discussion
to studies that combined the agents with UV, ozone, and
radicals. According to different mechanisms, agents used in
this study can be classified into four groups: antiseptics (CHX,





plasma interacts by the three main plasma constituents:
UV radiation, ozone, and radicals. For each agent different
mechanisms may be responsible for the increased effectivity
of the combination of agent and plasma.
Firstly, no information has been published about inter-
actions between radicals or radiation and antiseptics (CHX,
PHMB, and OCT). After enquiry, the manufacturers con-
firmed UV stability of the products. Our spectral measure-
ment of the antiseptics exposed before and after plasma
treatment affirmed their information: antiseptics were not
destroyed by the plasma treatment regime in our exper-
iments. The antimicrobial efficacy of antiseptics was not
decreased by additional plasma treatment as measured by
CFU. For saliva biofilms the combination exceeded the pure
plasma effect, which was corroborated by the live-dead
staining experiment. Both treatment orders increased the
antimicrobial effect, while prior plasma treatment tended to
somewhat stronger antimicrobial effects. For OCT there was
a significant difference between the two treatment orders: the
biofilm could be destroyed by plasma so that the antiseptic
could be more effective. Therefore, we might conclude that
plasma does not destroy the antiseptics but rather has an
additive effect in antiseptic treatment. For future medical
therapies the combination of antiseptics and plasma treat-
ment might be beneficial.
It was shown that the combination of UV and NaOCl
increased the inactivation of some phages, but without
any synergistic effects concerning E.coli and enterococci in
waste water [17]. The synergistic effect between hypochlorite
and radicals increases protein damage [18], which can be
relevant for the increase in antimicrobial effects. Because
of the high antimicrobial efficacy of NaOCl in single treat-
ment, combinations with Ar plasma lead to comparable
log
10
CFUs for saliva biofilm (𝑃 > 0.05). Nevertheless,
the combination with Ar plasma resulted in the highest
CFU reduction factor, which was confirmed with Live-
dead staining. The antimicrobial effect was not increased
for NaOCl plus Ar plasma but for Ar plasma plus NaOCl.
Regarding S. mutans biofilms and plaque our results are
consistent.
Thirdly, the antibiofilm effect of EDTA is based on the dis-
persal of the biofilm structure [19]. Our working hypothesis
was that after disruption of the biofilm matrix antimicrobial
agents like plasma can kill the bacteria directly without
being inhibited by the protective matrix. This explains why
antibiotics can act more effectively with EDTA [20]. UV in




is necessary for EDTA
degradation, whereas pure ozone did not alter the action
EDTA [21]. In plasma processes UV and ozone are developed.
The resulting OH radicals degrade EDTA without creating
toxic degradation products [22]. It is possible that EDTA was
destroyed by plasma and the main effect of this combination
is the dispersion of the biofilms by EDTA. EDTA showed
per se an antimicrobial effect which could be increased using
plasma. For S. mutans und saliva, Ar plasma plus EDTA
was significantly more effective than Ar plasma or EDTA
alone. According to our hypothesis, this synergistic effect is
a consequence of the biofilm dispersion and the resulting
better efficacy of plasma. To confirm this hypothesis, we
changed the treatment order: first plasma, then EDTA. This
order resulted in the same efficacy as that using CFU analysis.
Using Live-dead staining we found only minimal differences
between EDTAand plasma plus EDTAbut a higher reduction
of the live-dead ratio applying EDTA plus plasma (𝑃 <
0.05).This confirmed our hypothesis in agreement with other
research groups who have combined EDTA with antibiotics
[20].





known and is used to disinfect food packaging materials [23]





. The reaction is induced by the absorp-
tion of photons by hydrogen peroxide, which leads to the
production of OH radicals [25]. According to our hypothesis





and plasma. To test this hypothesis, we switched




and plasma too. We found the
same synergistic reduction effect after switching the order





treatment tended to increase antimicrobial
effects.
The antimicrobial effect of plasma may be attributed to
a complex interaction of its components, for example, UV,
radicals, ozone, and so forth. However, so far only single
components such as UV have been combined with agents
[18, 23, 26]. The current results deliver further information
to understand antimicrobial effects of plasma in combina-
tion with agents as compared with effects of combinations
between UV and agents because here a mixture of UV,
radicals, and so forth was effective.
There are some studies which determined the cytotoxic
potential of single treatments with plasma and agents [27–
29]. The toxic potential of the combination of plasma and
agents needs further clarification. More investigations are
necessary to identify the underlying mechanisms.
We performed in vitro studies. However, in vivo studies
are necessary to ensure that (i) antimicrobial effects are not
restricted to in vitro settings and (ii) application of combined
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treatments with Ar plasma and agents in clinical settings is
reasonable.
This is the first study evaluating the combined antimicro-
bial effect of plasmawith different agents using three different
biofilm models. The combination of plasma and agents
increased the antimicrobial efficacy of all tested compounds.
It supports the additional use of plasma treatment of dental
implants in addition to the often used chemicals and anti-
septic solutions. Thus, the combined treatment with plasma
and agents seems very beneficial, since the efficacy will be
increased, while no additional chemicals will be needed.
Furthermore, our results indicate that even a reduction of
commonly used agents could be possible when applied in
combination with Ar plasma, which could reduce the costs
for treatments as well as the possible risk for patients due to
the antimicrobial agents.
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